II‐VI Incorporated Announces Miniature Tunable Optical Filter for High Bit Rate DWDM Transmission
Mar 07, 2017 21:05 pm UTC| Business
PITTSBURGH, March 07, 2017 -- II‐VI Incorporated (NASDAQ:IIVI), a leading provider of solutions for next generation optical networks, today announced a miniature tunable optical filter for high bit rate DWDM...
MINDBODY Announces Schedule of Upcoming Investor Conference
Mar 07, 2017 21:05 pm UTC| Business
SAN LUIS OBISPO, Calif., March 07, 2017 -- MINDBODY, Inc. (NASDAQ:MB), the leading provider of cloud-based business management software for the wellness services industry and a rapidly growing consumer brand, today...
Mar 07, 2017 21:03 pm UTC| Business
First AAV gene therapy treatment for HoFH; interim trial update expected late 2017 ROCKVILLE, Md., March 07, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve...
Ekso Bionics Reports Fourth Quarter and Year End 2016 Results
Mar 07, 2017 21:03 pm UTC| Business
RICHMOND, Calif., March 07, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three and twelve months ended December 31, 2016. Recent Highlights...
Mar 07, 2017 21:02 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., March 07, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a corporate update for the fourth...
Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update
Mar 07, 2017 21:02 pm UTC| Business
Recent, highly favorable U.S. Patent and Trademark Office decision affirms and upholds fundamental CRISPR/Cas9 issued patents Extended CRISPR technology leadership with addition of novel and differentiated Cpf1 system,...
Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update
Mar 07, 2017 21:02 pm UTC| Business
Recent, highly favorable U.S. Patent and Trademark Office decision affirms and upholds fundamental CRISPR/Cas9 issued patents Extended CRISPR technology leadership with addition of novel and differentiated Cpf1 system,...